Fungal diseases at the medical front door

Br J Hosp Med (Lond). 2019 Mar 2;80(3):157-161. doi: 10.12968/hmed.2019.80.3.157.

Abstract

Fungal diseases are an increasingly recognized cause of mortality worldwide and often pose diagnostic challenges. This article focuses on common fungal diseases as they may present in the acute medical unit, looking at the initial investigation and management of four common diseases: Pneumocystis jirovecii pneumonia, cryptococcal meningitis, candidaemia and allergic bronchopulmonary aspergillosis. There is an increase in morbidity and mortality if these conditions are not correctly diagnosed and thus appropriate therapy is delayed. A better understanding of the initial investigation and management of these conditions will improve the outcome of patients with fungal diseases presenting to the 'medical front door'.

Publication types

  • Review

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Anti-Bacterial Agents / therapeutic use
  • Antifungal Agents / therapeutic use
  • Aspergillosis, Allergic Bronchopulmonary / diagnosis*
  • Aspergillosis, Allergic Bronchopulmonary / drug therapy
  • Candidemia / diagnosis*
  • Candidemia / drug therapy
  • Cross Infection / diagnosis*
  • Cross Infection / drug therapy
  • Humans
  • Immunocompromised Host
  • Meningitis, Cryptococcal / diagnosis*
  • Meningitis, Cryptococcal / drug therapy
  • Meningitis, Cryptococcal / immunology
  • Pneumonia, Pneumocystis / diagnosis*
  • Pneumonia, Pneumocystis / drug therapy
  • Pneumonia, Pneumocystis / immunology

Substances

  • Adrenal Cortex Hormones
  • Anti-Bacterial Agents
  • Antifungal Agents